This is the authors' abstract. We don't add key points for this paper.
Background Evidence suggests neuroinflammation is the main mechanism in cognitive dysfunction. The brain-derived neurotrophic factor (BDNF) is involved in learning and memory via binding to tyrosine kinase B (TrkB) receptors. Herein, we mainly tested roles of the BDNF-TrkB signaling pathway and its downstream cascades in lipopolysaccharide (LPS) induced cognitive dysfunction in mice. Methods Mice were treated with LPS and 7,8-DHF for 7 days, and learning and memory function was evaluated by the novel object recognition test (NORT). Western blot elucidated roles of the BDNF-TrkB signaling pathway and its downstream cascades in LPS mice. Results The NORT showed that LPS induced learning and memory deficits in mice. LPS increased the levels of IL-1β, IL-6, and TNF-α in the serum of mice. In the hippocampus and medial prefrontal cortex (mPFC) regions, LPS reduced protein levels of BDNF, p-TrkB, Bcl-2, p-ERK1/2, p-CaMK2, p-CREB and p-GluR1 and increased the expression of Bax. In the entorhinal cortex (EC), levels of BDNF, p-TrkB, Bcl-2, p-CaMK2 and p-CREB proteins were reduced and the protein level of Bax was increased in LPS mice. 7,8-DHF could alleviate these disorders in LPS mice and improved their learning and memory function, however, the TrkB antagonist ANA12 effectively reversed the effects of 7,8-DHF. Conclusion These results revealed that the BDNF-TrkB signaling pathway and its downstream cascades disorders contributed to neuroinflammation induced cognitive dysfunction in mice. 7,8-DHF could become a new therapeutic drug for cognitive dysfunction induced by BDNF-TrkB signaling pathway disorders in neurodegenerative diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: